| Dr David Nelson Mckinney, MD | |
|
7700 University Dr, West Chester, OH 45069-2505 | |
| (513) 475-7977 | |
| (513) 475-8267 |
| Full Name | Dr David Nelson Mckinney |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | 7700 University Dr, West Chester, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841519790 | NPI | - | NPPES |
| 0190678 | Medicaid | OH |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Cincinnati Physicians Company Llc | 2264344480 | 1339 |
News Archive
Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The University od Gothenburg, Sweden, have now developed a method which identifies the cancer's visible precursors with 97% certainty. The method, which is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery, may be introduced in patient care within five years.
More time in front of the TV set and higher exposure to TV adverts may lead to increased consumption of sweetened beverages among children. This is the conclusion of a new study from the University of Gothenburg, Sweden.
A new study published in the reputed journal Science in October 2020 reports the potential therapeutic value of the second type of host transmembrane receptor, called neuropilins, which attach to the spike protein of SARS-CoV-2 and may enhance its infectivity.
An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against recurring breast cancers that are resistant to standard treatments.
A new paper in the May 15th issue of Genes & Development reveals how a protein called Yin Yang 1 regulates early B cell development.
› Verified 3 days ago
| Entity Name | University Of Cincinnati Physicians Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801840434 PECOS PAC ID: 2264344480 Enrollment ID: O20031105000123 |
News Archive
Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The University od Gothenburg, Sweden, have now developed a method which identifies the cancer's visible precursors with 97% certainty. The method, which is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery, may be introduced in patient care within five years.
More time in front of the TV set and higher exposure to TV adverts may lead to increased consumption of sweetened beverages among children. This is the conclusion of a new study from the University of Gothenburg, Sweden.
A new study published in the reputed journal Science in October 2020 reports the potential therapeutic value of the second type of host transmembrane receptor, called neuropilins, which attach to the spike protein of SARS-CoV-2 and may enhance its infectivity.
An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against recurring breast cancers that are resistant to standard treatments.
A new paper in the May 15th issue of Genes & Development reveals how a protein called Yin Yang 1 regulates early B cell development.
› Verified 3 days ago
| Entity Name | Alliance Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437125572 PECOS PAC ID: 0840104360 Enrollment ID: O20031118000529 |
News Archive
Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The University od Gothenburg, Sweden, have now developed a method which identifies the cancer's visible precursors with 97% certainty. The method, which is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery, may be introduced in patient care within five years.
More time in front of the TV set and higher exposure to TV adverts may lead to increased consumption of sweetened beverages among children. This is the conclusion of a new study from the University of Gothenburg, Sweden.
A new study published in the reputed journal Science in October 2020 reports the potential therapeutic value of the second type of host transmembrane receptor, called neuropilins, which attach to the spike protein of SARS-CoV-2 and may enhance its infectivity.
An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against recurring breast cancers that are resistant to standard treatments.
A new paper in the May 15th issue of Genes & Development reveals how a protein called Yin Yang 1 regulates early B cell development.
› Verified 3 days ago
| Entity Name | Children's Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609915784 PECOS PAC ID: 8426955733 Enrollment ID: O20031216000035 |
News Archive
Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The University od Gothenburg, Sweden, have now developed a method which identifies the cancer's visible precursors with 97% certainty. The method, which is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery, may be introduced in patient care within five years.
More time in front of the TV set and higher exposure to TV adverts may lead to increased consumption of sweetened beverages among children. This is the conclusion of a new study from the University of Gothenburg, Sweden.
A new study published in the reputed journal Science in October 2020 reports the potential therapeutic value of the second type of host transmembrane receptor, called neuropilins, which attach to the spike protein of SARS-CoV-2 and may enhance its infectivity.
An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against recurring breast cancers that are resistant to standard treatments.
A new paper in the May 15th issue of Genes & Development reveals how a protein called Yin Yang 1 regulates early B cell development.
› Verified 3 days ago
| Entity Name | Kettering Independent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629387865 PECOS PAC ID: 3173710936 Enrollment ID: O20101207000425 |
News Archive
Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The University od Gothenburg, Sweden, have now developed a method which identifies the cancer's visible precursors with 97% certainty. The method, which is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery, may be introduced in patient care within five years.
More time in front of the TV set and higher exposure to TV adverts may lead to increased consumption of sweetened beverages among children. This is the conclusion of a new study from the University of Gothenburg, Sweden.
A new study published in the reputed journal Science in October 2020 reports the potential therapeutic value of the second type of host transmembrane receptor, called neuropilins, which attach to the spike protein of SARS-CoV-2 and may enhance its infectivity.
An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against recurring breast cancers that are resistant to standard treatments.
A new paper in the May 15th issue of Genes & Development reveals how a protein called Yin Yang 1 regulates early B cell development.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Nelson Mckinney, MD 7700 University Dr, West Chester, OH 45069-2505 Ph: (513) 475-7977 | Dr David Nelson Mckinney, MD 7700 University Dr, West Chester, OH 45069-2505 Ph: (513) 475-7977 |
News Archive
Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The University od Gothenburg, Sweden, have now developed a method which identifies the cancer's visible precursors with 97% certainty. The method, which is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery, may be introduced in patient care within five years.
More time in front of the TV set and higher exposure to TV adverts may lead to increased consumption of sweetened beverages among children. This is the conclusion of a new study from the University of Gothenburg, Sweden.
A new study published in the reputed journal Science in October 2020 reports the potential therapeutic value of the second type of host transmembrane receptor, called neuropilins, which attach to the spike protein of SARS-CoV-2 and may enhance its infectivity.
An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against recurring breast cancers that are resistant to standard treatments.
A new paper in the May 15th issue of Genes & Development reveals how a protein called Yin Yang 1 regulates early B cell development.
› Verified 3 days ago
John Dean Adler, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7675 Wellness Way, 4th Floor, West Chester, OH 45069 Phone: 513-475-8248 Fax: 513-475-7179 | |
James W Buckreus, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7675 Wellness Way, Suite 400, West Chester, OH 45069 Phone: 513-475-8588 Fax: 513-475-4598 | |
Emily G Hurley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7700 University Dr, West Chester, OH 45069 Phone: 513-475-8248 Fax: 513-475-8468 | |
Fares Alqara, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7700 University Dr, West Chester, OH 45069 Phone: 513-475-8248 Fax: 513-475-8468 | |
Michael A Thomas, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7675 Wellness Way, West Chester, OH 45069 Phone: 513-475-8588 Fax: 513-475-8267 | |
Shannel R Adams, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7675 Wellness Way Ste 315, West Chester, OH 45069 Phone: 513-475-7657 | |
Mickey M Karram, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7759 University Drive, Suite G, West Chester, OH 45069 Phone: 513-463-2500 Fax: 513-463-2510 |